SCHEMBL10051792

SCHEMBL10051792

c1ccc(N(c2ccc(-c3ccc(N(c4ccccc4)c4ccc5ccsc5c4)cc3)cc2)c2ccc3ccsc3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CA12 O43570 6/20 0.37
CA2 P00918 6/20 0.37
APP P05067 1/20 0.35
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
DYRK1A Q13627 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26546158 0.98 ALDH1A1 (0.36) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL26542795 0.98 ALDH1A1 (0.36) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL17011002 0.97 CA12 (0.37) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL31314474 0.95 ALDH1A1 (0.41) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL21872956 0.95 ALDH1A1 (0.41) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL24368904 0.89 ESR1 (0.42) ALDH1A1KDM4ECYP1A2MAPTCYP2C9
SCHEMBL10051791 0.87 CA2 (0.46) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL26546046 0.87 GPR3 (0.35) ALDH1A1CYP1A2MAPTCA12CA2
SCHEMBL17740653 0.85 CA2 (0.45) ALDH1A1L3MBTL1KDM4ECYP1A2CYP3A4
SCHEMBL24368901 0.84 ESR1 (0.43) ALDH1A1KDM4ECYP1A2MAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023190987-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2023-10-05 WO disclosed
US-9062152-B2 Organic electronic devices, including organic photovoltaic devices, polymers, and monomers SOLVAY USA, INC. (US) 2015-06-23 US disclosed
US-9062152-B2 Organic electronic devices, including organic photovoltaic devices, polymers, and monomers SOLVAY USA, INC. (US) 2015-06-23 US disclosed
US-20120283377-A1 ORGANIC ELECTRONIC DEVICES, INCLUDING ORGANIC PHOTOVOLTAIC DEVICES, POLYMERS, AND MONOMERS PLEXTRONICS, INC. 2012-11-08 US disclosed
US-20120283377-A1 ORGANIC ELECTRONIC DEVICES, INCLUDING ORGANIC PHOTOVOLTAIC DEVICES, POLYMERS, AND MONOMERS PLEXTRONICS, INC. 2012-11-08 US disclosed
WO-2012058209-A1 ORGANIC ELECTRONIC DEVICES, INCLUDING ORGANIC PHOTOVOLTAIC DEVICES, POLYMERS, AND MONOMERS PLEXTRONICS, INC. (US) 2012-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283377-A1 ORGANIC ELECTRONIC DEVICES, INCLUDING ORGANIC PHOTOVOLTAIC DEVICES, POLYMERS, AND MONOMERS OCIAD2, ETV6, RUVBL1 ALDH1A1 2555/4885L3MBTL1 808/4885KDM4E 668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.